CLINICAL_TRIALS
research
· 2025-08-08
Clinical Trial Update: Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma [EARLY_Phase 1]
Summary
An early-phase 1 trial evaluating chemoimmunotherapy followed by an allogeneic stem cell transplant for natural killer cell lymphoma/leukemia and related periph…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: New York Medical College | Conditions: NK-Cell Lymphoma, NK-Cell Leukemia | EARLY_Phase 1 | Status: RECRUITING